Clinical Trial Update: SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SBRT with a PD-1 inhibitor and thoracic hyperthermia for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC | Phase 2 | Status: UNKNOWN